Personal genomics and biotechnology company 23andMe (NASDAQ:ME) is laying off roughly 9% of its workforce as part of its restructuring efforts and cost-saving initiatives. CEO and co-founder Anne Wojcicki approved the layoff of the 75 employees, which will be completed largely in the ongoing quarter ending June 30, 2023.
https://www.tipranks.com/news/23andme-stock-nasdaqme-layoffs-on-the-horizon